NO175620C - Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel - Google Patents

Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Info

Publication number
NO175620C
NO175620C NO873244A NO873244A NO175620C NO 175620 C NO175620 C NO 175620C NO 873244 A NO873244 A NO 873244A NO 873244 A NO873244 A NO 873244A NO 175620 C NO175620 C NO 175620C
Authority
NO
Norway
Prior art keywords
pct
preparation
antitumor drug
sec
date
Prior art date
Application number
NO873244A
Other languages
English (en)
Norwegian (no)
Other versions
NO873244D0 (no
NO175620B (fi
NO873244L (no
Inventor
Hansjoerg Eibl
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO873244D0 publication Critical patent/NO873244D0/no
Publication of NO873244L publication Critical patent/NO873244L/no
Publication of NO175620B publication Critical patent/NO175620B/no
Publication of NO175620C publication Critical patent/NO175620C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicinal Preparation (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO873244A 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel NO175620C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28
PCT/EP1986/000706 WO1987003478A2 (fr) 1985-12-04 1986-12-04 Medicaments

Publications (4)

Publication Number Publication Date
NO873244D0 NO873244D0 (no) 1987-08-03
NO873244L NO873244L (no) 1987-10-01
NO175620B NO175620B (fi) 1994-08-01
NO175620C true NO175620C (no) 1994-11-09

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning

Country Status (15)

Country Link
US (2) US4837023A (fi)
EP (4) EP0248062B1 (fi)
JP (2) JPH0637393B2 (fi)
AT (2) ATE64529T1 (fi)
CA (2) CA1280369C (fi)
DE (4) DE3641491A1 (fi)
DK (2) DK172954B1 (fi)
ES (2) ES2032755T3 (fi)
FI (2) FI873364A (fi)
GR (2) GR3002487T3 (fi)
HU (2) HU208143B (fi)
IE (2) IE59778B1 (fi)
NO (2) NO175620C (fi)
PT (2) PT83872B (fi)
WO (2) WO1987003480A2 (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
ATE137973T1 (de) * 1989-08-10 1996-06-15 Sandoz Ag Phospholipide zur behandlung der multiplen sklerose
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
ES2108715T3 (es) * 1991-07-04 1998-01-01 Asta Medica Ag Procedimiento para la preparacion de alquilfosfocolinas y purificacion de las mismas.
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
EP0702556B1 (en) * 1993-06-10 2002-10-23 Wake Forest University (phospho)lipids for combatting hepatitis b virus infection
CA2171281C (en) 1993-09-09 1998-12-29 Romeo Rang Immunomodulating compositions from bile
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
WO1996006620A2 (en) * 1994-08-29 1996-03-07 Wake Forest University Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
AU1573495A (en) * 1995-02-10 1996-08-27 University Of British Columbia, The {4-hexadecyl-3-methoxy-butyl} phosphonic acid and its protienconjugates useful as anti-cancer agents
KR19980703088A (ko) 1995-03-16 1998-09-05 라카일레 지, 필리페 신규의 침전탄산칼슘 안료를 포함하는 잉크젯 기록지
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
SK284839B6 (sk) * 1998-01-22 2005-12-01 Zentaris Gmbh Použitie miltefozínu na výrobu lieku a farmaceutická kombinácia na liečenie leishmanózy
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
JP2004520175A (ja) * 2001-05-29 2004-07-08 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 金属−セラミック接合
US7551837B2 (en) * 2001-08-31 2009-06-23 Thomson Licensing Sequence counter for an audio visual stream
WO2003090757A1 (en) * 2002-04-26 2003-11-06 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
AR058397A1 (es) 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
ES2391226T3 (es) * 2006-12-20 2012-11-22 Alphaptose Gmbh Forma farmacéutica tópica que comprende compuestos de glicerol tri-sustituido
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
EP3616701A1 (en) 2011-06-24 2020-03-04 GRI Bio, Inc. Prevention and treatment of inflammatory conditions
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
CA3007970A1 (en) * 2014-12-09 2016-06-16 Gri Bio, Inc. Prevention and treatment of inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds

Also Published As

Publication number Publication date
DE19375061I2 (de) 2008-11-20
FI873363A (fi) 1987-08-03
IE863177L (en) 1987-06-04
GR3002487T3 (en) 1992-12-30
DE3641491A1 (de) 1987-09-17
US4837023A (en) 1989-06-06
HU208143B (en) 1993-08-30
WO1987003480A3 (fr) 1988-02-25
JPH0859677A (ja) 1996-03-05
PT83873B (pt) 1989-01-17
NO873244D0 (no) 1987-08-03
DK398587D0 (da) 1987-07-30
NO174877B (no) 1994-04-18
WO1987003480A2 (en) 1987-06-18
DK393187A (da) 1987-07-28
ATE75608T1 (de) 1992-05-15
NO175620B (fi) 1994-08-01
NO873244L (no) 1987-10-01
NO873243D0 (no) 1987-08-03
DK393187D0 (da) 1987-07-28
WO1987003478A3 (fr) 1987-09-24
DK172954B1 (da) 1999-10-18
NO873243L (no) 1987-10-02
NO174877C (no) 1994-07-27
EP0248062A1 (de) 1987-12-09
FI873364A0 (fi) 1987-08-03
JP2857084B2 (ja) 1999-02-10
EP0230575A2 (de) 1987-08-05
EP0225608A2 (de) 1987-06-16
EP0225608A3 (de) 1987-10-28
HU203201B (en) 1991-06-28
CA1338627C (en) 1996-10-01
JPH0637393B2 (ja) 1994-05-18
ES2032755T3 (es) 1993-03-01
EP0248062B1 (de) 1992-05-06
IE59777B1 (en) 1994-04-06
PT83873A (de) 1987-01-01
FI873363A0 (fi) 1987-08-03
ES2038215T3 (es) 1993-07-16
PT83872B (pt) 1989-01-17
EP0248047A1 (de) 1987-12-09
EP0248047B1 (de) 1991-06-19
DE3641379A1 (de) 1987-09-03
GR3005168T3 (fi) 1993-05-24
IE59778B1 (en) 1994-04-06
ATE64529T1 (de) 1991-07-15
WO1987003478A2 (fr) 1987-06-18
US5049552A (en) 1991-09-17
JPS63501719A (ja) 1988-07-14
HUT44441A (en) 1988-03-28
HUT44431A (en) 1988-03-28
FI873364A (fi) 1987-08-03
EP0230575A3 (de) 1987-12-02
DK398587A (da) 1987-07-30
IE863176L (en) 1987-06-04
DE3679908D1 (de) 1991-07-25
CA1280369C (en) 1991-02-19
PT83872A (de) 1987-01-01

Similar Documents

Publication Publication Date Title
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
FI830100L (fi) Nya 6-substituerade s-triazolo /3,4-a/ ftalazinderivat
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
MA19731A1 (fr) Isomere levogyre de la mequitazine , son procede de praparation et medicaments le contenant .
ES2129053T3 (es) Nuevos derivados de fosfolipidos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees